Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.73 Thousand USD | -79.42% |
| 2022 | 139.65 Thousand USD | -73.22% |
| 2021 | 521.55 Thousand USD | 310.89% |
| 2020 | 126.93 Thousand USD | 161.65% |
| 2019 | 48.51 Thousand USD | 13.03% |
| 2018 | 42.92 Thousand CAD | -93.49% |
| 2017 | 659.45 Thousand CAD | 102.95% |
| 2016 | 324.94 Thousand CAD | -17.34% |
| 2015 | 393.11 Thousand CAD | 203.01% |
| 2014 | 129.73 Thousand CAD | -67.07% |
| 2013 | 393.92 Thousand CAD | -46.63% |
| 2012 | 738.12 Thousand CAD | 81.19% |
| 2011 | 407.38 Thousand CAD | 185.7% |
| 2010 | 142.59 Thousand CAD | 14259200.0% |
| 2009 | 1.00 CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 26.1 Thousand USD | -9.14% |
| 2024 Q2 | 29.07 Thousand CAD | 11.35% |
| 2023 Q2 | 31.82 Thousand USD | -57.38% |
| 2023 Q1 | 74.67 Thousand USD | -46.53% |
| 2023 Q4 | 28.73 Thousand USD | -51.7% |
| 2023 FY | 28.73 Thousand USD | -79.42% |
| 2023 Q3 | 59.49 Thousand USD | 86.95% |
| 2022 FY | 139.65 Thousand USD | -73.22% |
| 2022 Q4 | 139.65 Thousand USD | -72.09% |
| 2022 Q2 | 698.99 Thousand CAD | 35.85% |
| 2022 Q3 | 500.42 Thousand USD | -28.41% |
| 2022 Q1 | 514.53 Thousand CAD | -1.35% |
| 2021 Q2 | 365.43 Thousand CAD | 1.37% |
| 2021 Q3 | 403.71 Thousand CAD | 10.47% |
| 2021 Q4 | 521.55 Thousand CAD | 29.19% |
| 2021 Q1 | 360.48 Thousand CAD | 122.92% |
| 2021 FY | 521.55 Thousand USD | 310.89% |
| 2020 Q3 | 145.73 Thousand CAD | -22.0% |
| 2020 FY | 126.93 Thousand USD | 161.65% |
| 2020 Q1 | 94.29 Thousand CAD | 49.89% |
| 2020 Q2 | 186.83 Thousand CAD | 98.14% |
| 2020 Q4 | 161.71 Thousand CAD | 10.96% |
| 2019 Q4 | 62.9 Thousand CAD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 FY | 48.51 Thousand USD | 13.03% |
| 2018 Q1 | 518.8 Thousand CAD | -37.21% |
| 2018 FY | 42.92 Thousand CAD | -93.49% |
| 2018 Q4 | 58.62 Thousand CAD | -83.73% |
| 2018 Q3 | 360.24 Thousand CAD | -13.01% |
| 2018 Q2 | 414.11 Thousand CAD | -20.18% |
| 2017 Q2 | 3.37 Million CAD | -6.98% |
| 2017 Q1 | 3.62 Million CAD | 732.11% |
| 2017 FY | 659.45 Thousand CAD | 102.95% |
| 2017 Q4 | 826.26 Thousand CAD | -75.38% |
| 2017 Q3 | 3.35 Million CAD | -0.51% |
| 2016 FY | 324.94 Thousand CAD | -17.34% |
| 2016 Q2 | 728.41 Thousand CAD | -29.13% |
| 2016 Q3 | 564.25 Thousand CAD | -22.54% |
| 2016 Q4 | 435.76 Thousand CAD | -22.77% |
| 2016 Q1 | 1.02 Million CAD | 88.22% |
| 2015 Q1 | 87.08 Thousand CAD | -32.88% |
| 2015 FY | 393.11 Thousand CAD | 203.01% |
| 2015 Q4 | 546.07 Thousand CAD | 1374.27% |
| 2015 Q3 | 37.04 Thousand CAD | -41.0% |
| 2015 Q2 | 62.78 Thousand CAD | -27.9% |
| 2014 FY | 129.73 Thousand CAD | -67.07% |
| 2014 Q4 | 129.73 Thousand CAD | -51.17% |
| 2014 Q3 | 265.69 Thousand CAD | 5.0% |
| 2014 Q2 | 253.03 Thousand CAD | -25.84% |
| 2014 Q1 | 341.22 Thousand CAD | -13.38% |
| 2013 Q1 | 718.26 Thousand CAD | -2.69% |
| 2013 Q2 | 688.6 Thousand CAD | -4.13% |
| 2013 Q3 | 1.04 Million CAD | 51.99% |
| 2013 Q4 | 393.92 Thousand CAD | -62.36% |
| 2013 FY | 393.92 Thousand CAD | -46.63% |
| 2012 Q2 | 839.59 Thousand CAD | -5.67% |
| 2012 Q1 | 890.1 Thousand CAD | 118.49% |
| 2012 FY | 738.12 Thousand CAD | 81.19% |
| 2012 Q3 | 764.46 Thousand CAD | -8.95% |
| 2012 Q4 | 738.12 Thousand CAD | -3.44% |
| 2011 Q1 | 140.42 Thousand CAD | -1.52% |
| 2011 Q4 | 407.38 Thousand CAD | -19.05% |
| 2011 FY | 407.38 Thousand CAD | 185.7% |
| 2011 Q2 | 609.85 Thousand CAD | 334.29% |
| 2011 Q3 | 503.26 Thousand CAD | -17.48% |
| 2010 Q3 | 143.74 Thousand CAD | -4.46% |
| 2010 Q4 | 142.59 Thousand CAD | -0.8% |
| 2010 FY | 142.59 Thousand CAD | 14259200.0% |
| 2010 Q2 | 150.46 Thousand CAD | 0.0% |
| 2009 FY | 1.00 CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 98.356% |
| BioElectronics Corporation | 144.38 Thousand USD | 80.099% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | 97.124% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 96.7% |
| Polarean Imaging plc | 10.86 Million USD | 99.736% |
| AVITA Medical, Inc. | 144.33 Million USD | 99.98% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | 90.907% |
| Össur hf. | 1.39 Billion USD | 99.998% |
| Zecotek Photonics Inc. | 2.57 Million USD | 98.883% |
| QHSLab, Inc. | 1.68 Million USD | 98.291% |
| Wellstar International, Inc. | 957.89 Thousand USD | 97.0% |
| Össur hf. | 1.39 Billion USD | 99.998% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 99.972% |
| Escalon Medical Corp. | 4.75 Million USD | 99.396% |
| Aurora Spine Corporation | 11.92 Million USD | 99.759% |
| BrainsWay Ltd. | 62.97 Million USD | 99.954% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 98.993% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 99.974% |
| Vivos Inc. | 1.61 Million USD | 98.215% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.999% |
| Kelyniam Global, Inc. | 1.63 Million USD | 98.24% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 97.618% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | 47.514% |
| Nanomix Corporation | 982.05 Thousand USD | 97.074% |
| Theraclion SA | 18.66 Million EUR | 99.846% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | 84.227% |
| Positron Corporation | 1.76 Million USD | 98.374% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 96.16% |
| Lombard Medical, Inc. | 67.76 Million USD | 99.958% |
| ALR Technologies Inc. | 193.21 Thousand USD | 85.128% |
| Stratec SE | 529.71 Million USD | 99.995% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 97.104% |
| Heart Tronics, Inc. | 4.04 Million USD | 99.29% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 98.701% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 99.86% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 99.872% |
| VMS Rehab Systems, Inc. | 4.45 USD | -645630.337% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 98.278% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 96.105% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 93.696% |
| United American Healthcare Corporation | 10.37 Million USD | 99.723% |
| ECGI Holdings, Inc. | 5.2 Million USD | 99.448% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | 14.97% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 98.656% |
| Urologix, Inc. | 5.66 Million USD | 99.493% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 98.725% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 99.859% |
| SS Innovations International, Inc. | 25.47 Million USD | 99.887% |
| Qualis Innovations, Inc. | 2431.00 USD | -1082.024% |
| Smith & Nephew plc | 9.97 Billion USD | 100.0% |
| NIOX Group Plc | 116.47 Million USD | 99.975% |
| Fuse Medical, Inc. | 16.25 Million USD | 99.823% |
| Broncus Holding Corporation | 195.75 Million USD | 99.985% |
| Brain Scientific Inc. | 11.74 Million USD | 99.755% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 97.262% |